Abiraterone acetate 250mg"''"'"'

Abiraterone acetate
ABIRASTERON 250  is a medication used in the treatment of advanced prostate cancer. It is typically prescribed for individuals with metastatic prostate cancer that has become resistant to other forms of hormone therapy, such as surgical castration (removal of the testicles) or drugs that lower testosterone levels. 
ABIRASTERON 250  is used in combination with other medications to treat metastatic castration-resistant prostate cancer (mCRPC), which means the cancer has spread beyond the prostate and is no longer responding to standard hormonal therapy.
ABIRASTERON 250  works by inhibiting an enzyme called CYP17A1, which is involved in the production of androgens (male hormones), including testosterone. By blocking this enzyme, abiraterone reduces the production of testosterone, which can slow down the growth of prostate cancer cells.
It is available under various brand names, with "Zytiga" being one of the well-known trade names.
ABIRASTERON 250  is usually taken in combination with another medication called prednisone or prednisolone. The corticosteroid (prednisone) is given to minimize side effects associated with abiraterone.
The dosing and schedule for ABIRASTERON 250 can vary, but it is typically taken as a daily oral tablet. It is essential to follow your healthcare provider's instructions regarding the dosage and timing of the medication.
Common side effects of ABIRASTERON 250 may include fatigue, joint pain, high blood pressure, fluid retention, and electrolyte imbalances. It can also lead to low levels of potassium in the blood (hypokalemia). Regular monitoring of blood pressure, electrolytes, and liver function is often required during treatment.
Before starting ABIRASTERON 250, inform your healthcare provider about any other medical conditions you have, as well as any medications you are taking. It can interact with certain medications, so a complete medication list is essential.
ABIRASTERON 250  is not intended for use in women and should not be used during pregnancy or breastfeeding.
ABIRASTERON 250 Regular monitoring of prostate-specific antigen (PSA) levels and imaging tests is typically performed to assess how well the treatment is working and to detect any disease progression.
ABIRASTERON 250  The duration of treatment with abiraterone acetate may vary depending on the individual's response to therapy and the progression of the cancer.
For further information please contact:
info@sterispharma.com
Order now - https://www.sterisonline.com/product/abirasteron-250-133650